Internist·Angiologist·Obesity medicine

Prevention built on data, not on impressions.

I am a physician-researcher in Brno, Czech Republic. I head the cardiovascular intensive care unit and the site of the Kardiovize population cohort study at St. Anne's University Hospital, and I teach internal medicine at Masaryk University.

Profile

Robert Prosecký, MD, PhD, MPH is an angiologist, internist and obesity specialist at the 2nd Department of Internal Medicine, St. Anne's University Hospital Brno and the Faculty of Medicine, Masaryk University. He heads the cardiovascular intensive care unit, the clinical nutrition outpatient clinic and the site of the Kardiovize population cohort study, which underpins his research.

He has worked at St. Anne's since 2002. He is board-certified in internal medicine (2010), completed certified training in angiology (2013), earned an MPH in 2017 and defended his PhD at Masaryk University in 2023. His work sits at the intersection of clinical nutrition, cardiometabolic prevention, obesity medicine and vascular medicine — from body-composition phenotyping to prediction modelling.

He teaches medical and nutrition therapy students at Masaryk University and is responsible for the Internal Medicine course for nutrition therapy students. He began teaching nutrition therapy students in 2009 and has been an assistant professor since May 2019. He is the scientific guarantor of the Czech national conference on current therapeutic options in obesity, held for the fifth time on 10 December 2026 in Brno.

Robert Prosecký
33documents indexed in Scopus
4,700citations
15h-index

Scopus, as of 30 July 2026 · Scopus profile · ORCID 0000-0002-3103-4962 · PubMed

Kardiovize Brno 2030

Kardiovize Brno 2030 is a population-based cohort study run by St. Anne's University Hospital Brno. It invited randomly selected residents of Brno aged 25 to 64, stratified by age and sex. The baseline examination in 2013–2014 reached its target of 1% of the city's population in that age range.

Alongside the classical risk factors the study measures less common ones: the cardio-ankle vascular index (CAVI), carotid intima-media thickness and body fat distribution. Serum, plasma and DNA are stored at −80 °C for further analyses. Follow-up examinations are planned every five years and the study is designed to run until 2030.

2,160participants at the baseline examination, 2013–2014Movsisyan et al., 2018
6,377randomly selected residents invited; 33.9% took partMovsisyan et al., 2018
755returned for the first follow-up examinationKunzova et al., 2022

I head the study site. The cohort is the data foundation of most of my published work, from body composition and blood pressure to prediction models of insulin resistance.

Cohort design and descriptive statistics (in Czech) →

Clinic, research and teaching

Cohort study

Kardiovize

I head the site of the population cohort study at the 2nd Department of Internal Medicine, St. Anne's University Hospital Brno. The cohort follows cardiovascular risk factors and metabolic syndrome in an ordinary urban population, and it is the data foundation of most of my published work.

Clinic

Cardiovascular ICU and clinical nutrition clinic

I have worked at St. Anne's University Hospital since 2002. Since 2019 I have headed the cardiovascular intensive care unit at the 2nd Department of Internal Medicine, and since 2024 the clinical nutrition outpatient clinic. My clinical work covers internal medicine, angiology, clinical nutrition and the treatment of obesity.

Prevention and models

Prevention programmes

I run prevention programmes focused on cardiometabolic risk. On cohort data I build prediction models of insulin resistance, with the emphasis on interpretability and TRIPOD+AI reporting rather than on maximum AUC.

Teaching

Faculty of Medicine, Masaryk University

I teach medical students and nutrition therapy students and I am responsible for the Internal Medicine course for nutrition therapy students. I began teaching nutrition therapy students in 2009 and have been an assistant professor since May 2019.

Selected publications

  1. 2023 Association of anthropometric and body composition parameters with the presence of hypertension in the Central European population: results from KardioVize 2030 study Acta Cardiologica · first author · PMID 37039634 · DOI
  2. 2024 Sarcopenia and adipose tissue evaluation by artificial intelligence predicts the overall survival after TAVI Scientific Reports · PMID 38632317 · DOI
  3. 2020 The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure Clinical and Experimental Pharmacology & Physiology · PMID 32083749 · DOI
  4. 2017 Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women: a 10-year follow-up Wiener klinische Wochenschrift · PMID 28913629 · DOI
  5. 2017 Matrix metalloproteinase-3 gene polymorphism (rs3025058) affects markers of atherosclerosis in type 2 diabetes mellitus VASA — Zeitschrift für Gefässkrankheiten · PMID 28521653 · DOI

All publications on PubMed →

Speaking topics

Body composition as a clinical tool: beyond BMI

BMI is a proxy, not a diagnosis. The talk shows what body-composition analysis adds beyond weight and waist circumference, how the metabolically healthy and unhealthy phenotypes of obesity differ, and where risk estimated from BMI parts ways with actual risk. Data from a population cohort.

cardiometabolic phenotyping · cohort data

Cardiometabolic prevention in population data

What a long-followed urban cohort shows about the distribution of risk factors, about differences between the sexes, and about where prevention programmes actually reach the patient and where they miss. The talk is a reading of data, not a review of guidelines.

prevention · epidemiology · Kardiovize

Obesity pharmacotherapy in the internist's office

A practical overview of current obesity pharmacotherapy at the level of drug classes: whom to treat, when to start, what to expect for weight and what for cardiometabolic outcomes. It covers the combination with lifestyle measures and interdisciplinary care.

obesity medicine · drug classes · indications

Prediction models you can defend

How to build a prediction model that survives both peer review and clinical common sense: choice of cohort, interpretability, calibration and TRIPOD+AI reporting, shown on a model of insulin resistance. For physicians and doctoral students; no statistical training required.

machine learning · insulin resistance · TRIPOD+AI

Education and memberships

2023
PhD, Faculty of Medicine, Masaryk University, Brno
2019
Assistant professor of internal medicine, 2nd Department of Internal Medicine, St. Anne's University Hospital Brno and Masaryk University
2017
MPH, Slovak Medical University in Bratislava
2013
Angiology, certified training course, Institute for Postgraduate Medical Education (IPVZ), Prague
2010
Board certification in internal medicine, IPVZ, Prague
since 2008
Czech Society of Hypertension
since 2010
Czech Society of Cardiology
since 2013
Czech Society of Angiology
since 2017
Czech Society of Clinical Nutrition and Intensive Metabolic Care
since 2018
Czech Society for Atherosclerosis
since 2019
Czech Society of Internal Medicine

Contact

Write to me directly. This site collects no personal data: there is no form, no analytics and no cookies.

robert.prosecky@fnusa.cz
robert.prosecky@gmail.com

2nd Department of Internal Medicine, St. Anne's University Hospital Brno
Pekařská 664/53, 602 00 Brno, Czech Republic

A short, medium and long version of my profile in English, ready for conference programmes, is on the Czech home page under the English tab.